USS Investment Management Ltd boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 8.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 41,855 shares of the company’s stock after purchasing an additional 3,387 shares during the quarter. USS Investment Management Ltd’s holdings in Cardinal Health were worth $8,602,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Cardinal Health by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after purchasing an additional 617,775 shares in the last quarter. State Street Corp boosted its position in Cardinal Health by 1.8% during the fourth quarter. State Street Corp now owns 12,509,230 shares of the company’s stock worth $2,570,647,000 after purchasing an additional 221,497 shares in the last quarter. Geode Capital Management LLC boosted its position in Cardinal Health by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after purchasing an additional 43,924 shares in the last quarter. Wellington Management Group LLP boosted its position in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Finally, Norges Bank purchased a new stake in Cardinal Health during the fourth quarter worth $790,344,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CAH has been the topic of a number of research analyst reports. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday. Wells Fargo & Company reduced their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. William Blair started coverage on Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Evercore reduced their price objective on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Finally, TD Cowen upped their price objective on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $246.93.
Cardinal Health Stock Up 1.2%
Shares of NYSE:CAH opened at $226.52 on Tuesday. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The stock’s fifty day simple moving average is $203.46 and its 200-day simple moving average is $208.92. The company has a market capitalization of $53.05 billion, a P/E ratio of 34.64, a P/E/G ratio of 1.22 and a beta of 0.52.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same period in the prior year, the business earned $2.35 earnings per share. The business’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.
Cardinal Health Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s payout ratio is currently 31.19%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
